Our results also indicated three levels of TGF-β1 expression were classified in SSc patients, although increased expression of TGF-β1 in SSc-fibroblasts was revealed with an average of total SSc biopsies (S1 Fig). This evidence concerns the gene TGFB1 and systemic sclerosis.